EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Role of Intestinal Barrier Disruption to Acute-on-Chronic Liver Failure

Julian Pohl, Dimitrios Aretakis, Frank Tacke, Cornelius Engelmann, Michael Sigal

Seminars in Liver Disease · 01.03.2025 · 45 (01) · 052-065

DOI: 10.1055/a-2516-2361 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Seminars in Liver Disease, erschienen am 01.03.2025. Verfasst von Julian Pohl und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatology and Gastroenterology, Campus Virchow-Klinikum and Campus Charité Mitte, Charité-Universitätsmedizin Berlin, Berlin, Germany. Hauptthemen laut MEDLINE: Acute-On-Chronic Liver Failure, Intestinal Mucosa, Gastrointestinal Microbiome, Liver. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 141 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute-on-chronic liver failure (ACLF) is a severe condition in patients with decompensated liver cirrhosis, marked by high short-term mortality. Recent experimental and clinical evidence has linked intestinal dysfunction to both the initiation of ACLF as well as disease outcome. This review discusses the significant role of the gut–liver axis in ACLF pathogenesis, highlighting recent advances. Gut mucosal barrier disruption, gut dysbiosis, and bacterial translocation emerge as key factors contributing to systemic inflammation in ACLF. Different approaches of therapeutically targeting the gut–liver axis via farnesoid X receptor agonists, nonselective beta receptor blockers, antibiotics, and probiotics are discussed as potential strategies mitigating ACLF progression. The importance of understanding the distinct pathophysiology of ACLF compared with other stages of liver cirrhosis is highlighted. In conclusion, research findings suggest that disruption of intestinal integrity may be an integral component of ACLF pathogenesis, paving the way for novel diagnostic and therapeutic approaches to manage this syndrome more effectively.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute-On-Chronic Liver FailureIntestinal MucosaGastrointestinal MicrobiomeLiverLiver CirrhosisHumansBacterial TranslocationDysbiosisAnimalsProbiotics

Autor:innen und Institutionen

  • Department of Hepatology and Gastroenterology, Campus Virchow-Klinikum and Campus Charité Mitte, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Institute for Liver and Digestive Health, University College London, London, United Kingdom.
  • Berlin Institute for Medical Systems Biology (BIMSB), Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.

Zitieren

APA

Pohl, J., Aretakis, D., Tacke, F., Engelmann, C., & Sigal, M. (2025). Role of Intestinal Barrier Disruption to Acute-on-Chronic Liver Failure. Seminars in Liver Disease, 45(01), 052-065. https://doi.org/10.1055/a-2516-2361

Vancouver

Pohl J, Aretakis D, Tacke F, Engelmann C, Sigal M. Role of Intestinal Barrier Disruption to Acute-on-Chronic Liver Failure. Seminars in Liver Disease. 2025;45(01):052-065. doi:10.1055/a-2516-2361

BibTeX
@article{Pohl2025,
  author = {Pohl, Julian and Aretakis, Dimitrios and Tacke, Frank and Engelmann, Cornelius and Sigal, Michael},
  title = {Role of Intestinal Barrier Disruption to Acute-on-Chronic Liver Failure},
  journal = {Seminars in Liver Disease},
  year = {2025},
  volume = {45},
  number = {01},
  pages = {052--065},
  doi = {10.1055/a-2516-2361}
}
Kostenlos starten →